What is a stock summary page? Click here for an overview.
Business Description
Dr Hoenle AG
ISIN : DE0005157101
Compare
Compare
Traded in other countries / regions
HNL.Germany0O27.UKHNLG.AustriaDRHNF.USA IPO Date
2007-11-19Description
Dr Hoenle AG supplies industrial UV technology. It operates in three business segments: The Adhesive Systems segment in addition to industrial adhesives supplies adhesive curing systems. The Disinfection segment combines activities in the areas of industrial water, surface and air disinfection, including microbiological testing. The Curing segment sells equipment for surface drying and curing paints, varnishes and other coatings. Geographically, the company operates in Germany and other countries. The key revenue portion is from Germany.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.14 | |||||
| Equity-to-Asset | 0.51 | |||||
| Debt-to-Equity | 0.69 | |||||
| Debt-to-EBITDA | 15.16 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.4 | |||||
| Beneish M-Score | -3.3 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -5 | |||||
| 3-Year EBITDA Growth Rate | -39.7 | |||||
| 3-Year EPS without NRI Growth Rate | -39.1 | |||||
| 3-Year Book Growth Rate | -10.5 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 8.67 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 74.14 | |||||
| 9-Day RSI | 60.8 | |||||
| 14-Day RSI | 56.28 | |||||
| 3-1 Month Momentum % | 31.88 | |||||
| 6-1 Month Momentum % | -14.66 | |||||
| 12-1 Month Momentum % | -45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.89 | |||||
| Quick Ratio | 0.86 | |||||
| Cash Ratio | 0.24 | |||||
| Days Inventory | 315.6 | |||||
| Days Sales Outstanding | 49.88 | |||||
| Days Payable | 60.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 2.52 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 59.82 | |||||
| Operating Margin % | -10.21 | |||||
| Net Margin % | -13.46 | |||||
| FCF Margin % | 1.47 | |||||
| ROE % | -14.78 | |||||
| ROA % | -7.96 | |||||
| ROIC % | -7.23 | |||||
| 3-Year ROIIC % | 32.27 | |||||
| ROC (Joel Greenblatt) % | -8.76 | |||||
| ROCE % | -7.28 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 97 | |||||
| Shiller PE Ratio | 12.94 | |||||
| PS Ratio | 0.64 | |||||
| PB Ratio | 0.77 | |||||
| Price-to-Tangible-Book | 0.89 | |||||
| Price-to-Free-Cash-Flow | 43.16 | |||||
| Price-to-Operating-Cash-Flow | 17.06 | |||||
| EV-to-EBIT | -11 | |||||
| EV-to-EBITDA | 29.68 | |||||
| EV-to-Revenue | 1.1 | |||||
| EV-to-FCF | 75.18 | |||||
| Price-to-GF-Value | 0.57 | |||||
| Price-to-Median-PS-Value | 0.36 | |||||
| Earnings Yield (Greenblatt) % | -9.09 | |||||
| FCF Yield % | 2.39 | |||||
| Forward Rate of Return (Yacktman) % | -49.96 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Dr Hoenle AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 96.352 | ||
| EPS (TTM) (€) | -2.134 | ||
| Beta | 1.9 | ||
| 3-Year Sharpe Ratio | -0.67 | ||
| 3-Year Sortino Ratio | -0.86 | ||
| Volatility % | 50.57 | ||
| 14-Day RSI | 56.28 | ||
| 14-Day ATR (€) | 0.24573 | ||
| 20-Day SMA (€) | 9.493963 | ||
| 12-1 Month Momentum % | -45 | ||
| 52-Week Range (€) | 7.06 - 20 | ||
| Shares Outstanding (Mil) | 6.06 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Dr Hoenle AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Dr Hoenle AG Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Dr Hoenle AG Frequently Asked Questions
What is Dr Hoenle AG(LTS:0O27)'s stock price today?
The current price of LTS:0O27 is €9.70. The 52 week high of LTS:0O27 is €20.00 and 52 week low is €7.06.
When is next earnings date of Dr Hoenle AG(LTS:0O27)?
The next earnings date of Dr Hoenle AG(LTS:0O27) is .
Does Dr Hoenle AG(LTS:0O27) pay dividends? If so, how much?
Dr Hoenle AG(LTS:0O27) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers